📰 Master Trial News
Master Trial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Master Trial. Real-time updates on events, politics, business and more.
January 29, 2024
A key opinion leader explores the integration of bispecifics into MM therapy regimens.
January 29, 2024
Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.
July 11, 2023
A panel of experts reflects on treatment duration and its role in optimizing management of patients with newly diagnosed multiple myeloma.
June 1, 2023
Natalie S. Callander, MD, discusses several ongoing and planned clinical trials evaluating the use of novel therapeutic regimens in multiple myeloma.
April 7, 2023
Natalie S. Callander, MD, discusses the significance of the phase 3 ATLAS, phase 2 FORTE, and phase 2 MASTER trials in patients with multiple myeloma.
December 5, 2022
05.12.2022 - SEATTLE, Dec. 05, 2022 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), together with its collaborators, will present data from more than 30 abstracts showcasing the benefit of Adaptive’s next-generation sequencing ...
August 11, 2022
In pediatric trials, answers do not come quickly. The trials are time consuming, and many sites are required. That means costly studies and an end...
May 20, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual...